Markers of bone formation (bone-specific alkaline phosphatase [BAP]) and bone resorption (tartrate-resistant acid phosphatase 5b [TRACP-5b]) can serve as predictors of cardiovascular morbidity and mortality in patients with CKD [16]. This evidence concerns the gene ACP5 and chronic kidney disease.